Target intelligence / Profile preview

Nuclear factor erythroid 2-related factor 2 signaling pathway (Nrf2 pathway)

Target
Nrf2 pathway
Molecular classification
Other
01

Overview

The term "Oxidative stress pathways/retinal cell protection" does not refer to a single molecule or receptor but rather encompasses a group of interconnected molecular pathways that regulate the cellular response to oxidative damage in retinal cells. The most prominent among these is the Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, which plays a central role in defending against oxidative stress by upregulating antioxidant and cytoprotective genes such as heme oxygenase 1 and NAD(P)H quinone oxidoreductase. Activation of this pathway—often through upstream signals like PI3K/Akt—protects retinal pigment epithelial cells and ganglion cells from injury caused by reactive oxygen species, contributing to the prevention or mitigation of diseases such as age-related macular degeneration and glaucoma. Small molecules including triptonide, triptolide, and certain flavonoids have been shown experimentally to activate this protective mechanism. However, since "oxidative stress pathways/retinal cell protection" is not itself a discrete molecular target but rather describes multiple overlapping biological processes involving several proteins and regulatory networks—including and not limited to Nrf2—the entry should be flagged as incorrect for use as a canonical therapeutic target name[1][3][5].

Other names
Keap1/Nrf2/ARE pathwayNrf2 signalingPI3K/Akt/Nrf2 axisAntioxidant response element (ARE) pathway
02

Mechanism of action

Activation of Nrf2 to induce antioxidant gene expression (e.g., HO1, NQO1); Inhibition of oxidative stress-induced cell death in retinal cells and ganglion cells.

03

Biological functions

Regulation of oxidative stressCell protectionAntioxidant responseInflammation modulation
04

Disease associations

Age-related macular degeneration (AMD)GlaucomaRetinal degenerative diseasesDiabetic retinopathy
05

Interacting drugs

Triptonide

2 more in the full profile.

06

Biomarkers

Heme oxygenase 1 (HO1)NAD(P)H quinone oxidoreductase 1 (NQO1)Gamma-glutamyl-cysteine ligase catalytic subunit

Beyond the preview

Go deeper on Nuclear factor erythroid 2-related factor 2 signaling pathway (Nrf2 pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor erythroid 2-related factor 2 signaling pathway (Nrf2 pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call